Freeline Closes $120 Million Series C Financing Round Supported by leading international investors led by Novo Holdings A/S, Eventide Asset Management and Wellington Management Company – London, 30 June, 2020 – Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, today announced the closing of a $120 million extended Series C financing. The financing augments Syncona’s previously announced Series C investment in Freeline […]Read More
Cambridge Spin-out PharmEnable Raises £1.8 million for Drug Discovery Expansion £1.8m seed financing led by Cambridge Enterprise alongside angel investors and life science investment funds Using advanced medicinal chemistry and AI approaches to develop highly complex and specific drug candidate molecules Will enable in-house drug discovery across a number of therapeutic areas including cancer and […]Read More
AI HRTech Startup Recruitment Smart raises £400 K Pre-Series A funding round from Future Fund to expand HR Digital solution Recruitment Smart has so far hired shortlisted 200,000 candidates in Europe, Asia and Middle east and the AI algorithm can predict the best hires for organizations. LONDON: Recruitment Smart is a London based HR Tech […]Read More
June 30th, 2020 Symmetrical.ai closes €5.6M ($6.3M) Seed funding to bring ethical finance to employees in Europe Financial well being represents one of the most challenging problems facing society today. Symmetrical.ai is addressing this problem at its core, providing ethical financial products in partnership with employers to enable employees to better manage their financial and […]Read More